Background: Among deep extremity soft tissue sarcomas, skin ulceration is infrequent. Fungating sarcomas may lead to infection or clinically significant bleeding. Data regarding management of ulcerating sarcomas is lacking. We sought to evaluate the outcomes of different treatments for these tumors.
Introduction
Soft tissue sarcoma represents 1% of all malignancies in adults, half of which originate in the extremity [1] . With poor overall response rates to cytotoxic chemotherapy, treatment is primarily surgical resection with or without radiation therapy [2] . For many years, amputation was thought to represent the best chance for cure, until
Rosenberg's landmark trial demonstrated similar survival with limb-sparing resection followed by radiation therapy [3] . Peri-operative radiation therapy has improved rates of negative margins and local recurrence [4] [5] [6] . Neoadjuvant versus adjuvant radiation have been previously compared [7, 8] . Wound complications are more common with neoadjuvant radiation therapy, which is a significant consideration in the setting of increasing tumor sizes leading to larger wound defects and potential need for complex coverage techniques [7] . Conversely, joint fibrosis and decreased functionality is more problematic following adjuvant treatment [9] . Radiation therapy has therefore become standard of care for extremity soft tissue sarcoma, either pre-operatively for at-risk margins or post-operatively for positive margins.
Ulcerating or fungating soft tissue sarcomas are unusual but often indicate aggressive disease [10] . Ulceration is more likely with dermatofibrosarcoma protuberans or in areas with less soft tissue depth, such as the pretibial area or dorsal foot [11] . In the setting of ulceration, radiation therapy might further worsen soft tissue integrity, which in turn could either preclude primary soft tissue coverage of the wound defect or increase chances of wound complications, such as infection or delayed healing [11] . Given these risks, practitioners are more likely to avoid neoadjuvant radiation therapy for fungating sarcomas. Furthermore, some have considered ulceration to be an indication for amputation [12, 13] . We sought to evaluate our experience with fungating extremity soft tissue sarcomas, particularly in regard to method of resection, wound complications, and radiation therapy.
Methods
This was a two-institution collaborative observational study between City of Hope National Medical Center and Massachusetts General Hospital, conducted from January 2000 to January 2018 with bi-institutional review board approval. Patients provided consent for pictures of their tumors to be used for educational purposes.
Retrospective chart review of the institutions' prospectively maintained sarcoma databases was performed. We identified patients with locally advanced extremity soft tissue sarcoma with explicitly documented descriptions using words such as 'fungating' or 'ulcerating' in either consultation or operative notes. Soft tissue erosion was confirmed to have occurred prior to administration of neoadjuvant therapy. Patients with dermatofibrosarcoma protuberans or epithelioid soft tissue sarcoma were excluded due to their superficial location and inherent propensity for dermal erosion. Demographic, clinicopathologic, and operative data were collected. Specific attention was given to sequence of surgical and radiation treatment, method of surgical treatment, and post-operative wound complications.
Statistical analysis was performed with STATA version 14.0 (StataCorp, College Station, TX) and JMP Pro version 14.1 (SAS Institute, Cary, NC). A p value of <0.05 was considered significant. Categorical variables were expressed as percentages and analyzed using Pearson's χ 2 test. Continuous variables were expressed as median with interquartile range (IQR). Progression-free survival (PFS), overall survival (OS), and disease-specific survival (DSS) were calculated from time of resection or amputation. Univariate Cox proportional hazards analyses were performed with PFS, OS, and DSS as outcome variables. Multivariate analyses were precluded by the size of the patient cohort.
Results
Of 588 City of Hope patients screened, 18 (3.1%) had an extremity soft tissue sarcoma with specific documentation of overlying skin ulceration. An additional four patients were identified from Massachusetts General Hospital. Patient demographic and disease characteristics are presented in table 1.
Examples of fungating extremity sarcomas are shown in figure 1. Patients more frequently had tumors of the distal versus proximal extremity and were nearly all stage III or IV. The most frequent histology was undifferentiated pleomorphic sarcoma. One-third underwent amputation and one-third received adjuvant radiation. Amputation was less frequently performed in later years of the study. No patient was treated with neoadjuvant radiation. Onequarter had a wound complication of either delayed healing or infection.
The cohort was stratified by development of a wound complication and compared by tumor size, operative approach, and receipt of adjuvant radiation therapy ( Table  2) . Increasing tumor size, limb-preserving resection, and adjuvant radiation did not differ between the groups. Of note, only one of seven patients (14%) who underwent adjuvant radiation therapy had a wound complication.
Local recurrence was identified in three patients overall (14%), whereas distant disease recurrence developed in seven patients (32%). All local recurrences were found after wide local excision (n=3 of 15, 20%). All seven patients who underwent adjuvant radiation therapy had undergone limb-preserving resection; among them, one (14%) developed local recurrence.
Patient, clinicopathologic, and treatment factors were evaluated in terms of progression-free, overall, and disease-specific survival ( Table 3 ). Median PFS was 15.1 months (IQR 6.0 to not reached). Median OS was 37.4 months (IQR 11.0 to 75.6). Median DSS was 37.4 months (IQR 15.3 to not reached).The only factor associated with survival was disease stage, where stage III was associated with improved PFS compared to stage IV (HR 0.2, p = 0.016).
Discussion
This study demonstrates that among patients with fungating soft tissue sarcoma of the extremity, the development of wound complications was not significantly affected by method of resection or administration of adjuvant radiation. Wound infection or delayed healing occurred in approximately 25% of patients overall and was evenly distributed between amputation and limbpreserving resection. Wound complications were more frequent among patients who did not receive adjuvant radiation, which may have prevented patients from being considered for adjuvant treatment. Evaluating patients who did undergo radiation therapy, the rate of wound complications was very similar to that reported by O'Sullivan et al. [7] . This would suggest that as in nonulcerated extremity soft tissue sarcoma, the combination of wide local resection and adjuvant radiation for ulcerated tumors provides the opportunity for local control with a similar risk of local complications. Even in the absence of adjuvant radiotherapy, the rate of local recurrence was low in this cohort of locally advanced extremity sarcoma.
The efficacy of combined resection and radiation treatment in the neoadjuvant setting for fungating extremity soft tissue sarcoma remains to be evaluated. Indeed, there is likely to be resistance to the idea of pre-operative radiation therapy given the perceived prohibitive risk of wound complications. O'Sullivan et al. reported a complication rate of 33% among nonulcerating patients who received pre-operative radiation [7] . Potter et al. suggested that neoadjuvant radiation is essentially contraindicated in ulcerating patients, with the example of a 100% rate of wound complications for the two patients who underwent pre-operative radiation in their series [11] . At least some of this risk may be mitigated by use of non-radiated free flap microvascular reconstruction techniques [14, 15] . However, significant progression of ulceration due to radiation therapy may require larger tissue flaps and could potentially alter the proposed resection, perhaps precluding flap coverage for some patients. With planned free flap reconstruction, a neoadjuvant radiation therapy treatment plan may be pursued preferentially for sarcomas with limited areas of ulceration. The short-and long-term results of such an approach remain to be prospectively studied. Newer radiation techniques such as intensity modulated radiation therapy (IMRT) utilize more tailored radiation treatment plans and potentially improve outcomes, largely supplanting conventional external beam radiation [16, 17] . Application of (IMRT) in the pre-operative setting allows improved targeting of the tumor, reducing overall dose volume and minimizing the exposure to adjacent tissue without compromising outcomes [18, 19] . Despite the benefits of IMRT, a complete treatment course entails administration of 50 Gy of radiation given over 25 to 28 fractions. Progression of ulceration may be less with IMRT but remains a serious concern for such patients, and some may not tolerate the full course of treatment. Failure to complete the prescribed course of radiation may diminish its potential benefit and facilitate wound progression, which may compromise the planned resection. Conversely, post-operative treatment increases the total dose administered with reduced ability to selectively treat the resection bed, leading to additional toxicity to adjacent tissues [9, 20] . Studies comparing neoadjuvant IMRT to more traditional approaches in terms of wound complications are still lacking. In addition, the benefit of intra-operative radiation boost followed by more moderate post-operative radiation may provide an alternative treatment regimen for fungating tumors. Although rare in incidence, fungating soft tissue sarcomas can be considered as two intertwined issues, that of the malignancy and that of the ulcerating wound. The sarcoma itself must be addressed in order to optimally treat the patient. While that neoplastic process will inhibit local wound healing and promote progression of the ulceration, advanced wound care methods likely have a role in the care of such patients [21, 22] . This is particularly true if practitioners are to effectively treat the wounds during and immediately following treatment courses of neoadjuvant radiation. In the setting of widely metastatic disease, local control of fungating soft tissue malignancy with palliative intent can provide symptom relief for selected patients [23] . In this series, approximately one-quarter of patients had metastatic disease but underwent resection for local control.
Limitations of this study include its retrospective nature and small patient cohort given the relative rarity of ulcerating extremity sarcoma. With the small sample size, we were unable to fully elucidate risk factors for PFS, DSS, and OS without appropriately powered multivariate analyses. In addition, there may have been some selection bias for administration of adjuvant radiation based on performance of amputation or post-operative wound complications.
In summary, we found that among patients with fungating soft tissue sarcomas of the extremity, the combination of limb-sparing surgery and adjuvant radiation provided rates of local control and wound complications comparable to series of patients with non-fungating lesions. Our results suggest that other considerations should drive decision making regarding amputation or limb-sparing surgery, even in this population of patients with generally advanced disease.
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